NYSE · VATE
Industrials · Engineering & Construction
$5.51
Down-$0.29 (-5.00%)
Updated Nov 2, 2026, 3:41 AM
SID Score
4.1/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · VATE
1M range · 0 trading sessions · Daily adjusted prices
VATE does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
The latest Smart Investors Daily articles mentioning VATE.
Company
Market Activity
Research & News
VATE research
Company profile and research snapshot.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Benzinga · Oct 12, 2026
Innovate (NYSE:VATE) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you by Benzinga APIs.
Yahoo · Sep 18, 2026
AMD, Linde and Amgen highlight AI demand, contracted growth and drug launches, while supply, margin and pipeline risks remain key factors.
Yahoo · Aug 29, 2026
On August 10, IES Holdings, Inc. (NASDAQ:IESC) announced a definitive agreement to acquire DBM Global from INNOVATE Corp. (NYSE:VATE) for approximately $650 million in combined cash and stock ($685 million total consideration including minority interest buyouts and tax election payments). This major structural deal reshapes both companies, but their underlying financial trajectories explain why the […]
SeekingAlpha · Aug 13, 2026
INNOVATE Corp (VATE) sells DBM Global, shifting to a biotech-style MediBeacon bet. Click here to read my most recent analysis of VATE stock.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning VATE.
